Hancox, GB
Christopher N. Hancox, Huntingdon GB
Patent application number | Description | Published |
---|---|---|
20150295336 | SPRING POWER CONTACT HAVING NON-LINEAR SLOT - A power supply apparatus receives a voltage from power rails on a circuit board. The power supply apparatus comprises a frame and arms connected to the frame. Each of the arms comprises a contact end. The frame positions the contact end of each of the arms to contact the power rails of the circuit board. The contact end is biased towards the power rails to maintain the contact end in contact with the power rails. The contact end comprises a curved planar surface having a first edge and a second edge that terminates at an end edge. The first edge and the second edge follow a curved line, while the end edge follows a straight line. The contact end comprises a non-linear slot extending from the end edge along the curved planar surface and is positioned equally between the first edge and the second edge. | 10-15-2015 |
James Hancox, Edinburgh GB
Patent application number | Description | Published |
---|---|---|
20160005218 | IMAGE RENDERING APPARATUS AND METHOD - An image rendering apparatus comprises an image data unit for obtaining volumetric image data representative of a three-dimensional region, a rendering unit configured to perform a rendering process on the volumetric image data that includes a sampling process that comprises, for each of a plurality of sampling paths, determining a respective color or grayscale value for a corresponding pixel based on a plurality of sampled points along the sampling path. For each sampling path, the sampling process performed by the rendering unit comprises for each of at least some of the sampled points, calculating a significance factor for the sampled point based on accumulated opacity along the sampling path for the sampled point, selecting for the sampled point one of a plurality of rendering calculation processes in dependence on the calculated significance factor, and performing the selected rendering calculation process to obtain at least one image data value for the sampled point. For each sampling path the rendering unit is configured to determine the color or grayscale value for the corresponding pixel based on the determined image data values for the plurality of sampled points for the path. | 01-07-2016 |
Michael Richard Hancox, Herts GB
Patent application number | Description | Published |
---|---|---|
20140106922 | OIL SCAVENGE ARRANGEMENT - An epicyclic gearbox including: a sun gear, a ring gear, an array of planet gears that each mesh with the sun gear and the ring gear and rotate relative thereto, and a planet carrier that couples the planet gears in relative position to each other. The planet carrier includes interplanetary portions that are located between adjacent pairs of planet gears and have a first and a second circumferential surface facing each adjacent planet gear; and direction features on at least one of the circumferential surfaces that, in use, direct fluid ejected with a radial component from the planet gears and direct it with an axial component. | 04-17-2014 |
Timothy C. Hancox, Slough GB
Patent application number | Description | Published |
---|---|---|
20080207609 | Pharmaceutical compounds - Fused pyrimidines of formula (I): | 08-28-2008 |
20080207611 | Pharmaceutical compounds - Fused pyrimidines of formula (I): | 08-28-2008 |
20100234370 | PHARMACEUTICAL COMPOUNDS - Fused pyrimidines of formula (I): | 09-16-2010 |
20100280027 | PHARMACEUTICAL COMPOUNDS - Provided herein are methods of treating diseases or disorders arising from abnormal cell growth, function or behavior associated with PI3 kinase, which method includes administering to a patient in need thereof a compound that is a fused pyrimidine of formula (I): | 11-04-2010 |
20120258966 | PHARMACEUTICAL COMPOUNDS - Fused pyrimidines of formula (I): | 10-11-2012 |
20130317017 | PHARMACEUTICAL COMPOUNDS - Fused pyrimidines of formula (I): | 11-28-2013 |
20140294946 | PHARMACEUTICAL COMPOUNDS - Fused pyrimidines of formula (I): | 10-02-2014 |
Timothy C. Hancox, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20090209559 | PHARMACEUTICAL COMPOUNDS - Fused pyrimidines of formula (I): | 08-20-2009 |
Timothy Colin Hancox, Slough GB
Patent application number | Description | Published |
---|---|---|
20110098270 | THIAZOLOPYRIMIDINES AND THEIR USE AS INHIBITORS OF PHOSPHATIDYLINOSITOL-3 KINASE - Thiazolopyrimidine compounds of formula I, where W represents a thiazole ring, selectively inhibit the p110 delta subtype of PI3 Kinase (PI3K), and are useful for treating diseases and disorders arising from abnormal cell growth, function or behaviour associated with PI3 kinase such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders. | 04-28-2011 |
20120283257 | PHARMACEUTICAL COMPOUNDS - Thienopyrimidines of formula (Ia) or (Ib): | 11-08-2012 |
Timothy Colin Hancox, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20100016306 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITORS - Thienopyrimidines of formula (Ia) or (Ib): | 01-21-2010 |
20100130496 | PYRIMIDINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE - The invention provides a pyrimidine compound of formula (I): | 05-27-2010 |
20100190769 | THIAZOLOPYRIMIDINES AND THEIR USE AS INHIBITORS OF PHOSPHATIDYLINOSITOL-3 KINASE - Thiazolopyrimidines of formula (I): wherein W represents a thiazole ring; R | 07-29-2010 |
20100210646 | 2-MORPHOLIN-4-YL-PYRIMIDINES AS PI3K INHIBITORS - The invention provides a pyrimidine compound of formula (I): | 08-19-2010 |
20110021496 | THIENOPYRIMIDINE DERIVATIVES AS P13K INHIBITORS - Thienopyrimidines of formula (I) wherein W and R | 01-27-2011 |
20110230464 | PURINE DERIVATIVES USEFUL AS P13 KINASE INHIBITORS - This invention provides a compound which is a purine of formula (Ia) or (Ib): and the pharmaceutically acceptable salts thereof that are inhibitors of PI3K and a selective for the p110δ isoform, which is a class Ia PI3 kinase, over other class Ia PI3 kinases and over class Ib kinases. The compounds may be used to treat diseases and disorders arising from abnormal cell growth, function or behaviour associated with PI3 kinase such as cancer immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders. | 09-22-2011 |
Ursula Joy Hancox, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20160022690 | COMBINATION TREATMENT - The present invention relates to the use of combinations comprising 8-[(1R)-1-(3,5-difluorophenylamino)ethyl]-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide or a pharmaceutically acceptable salt thereof and a taxane in the treatment or prophylaxis of cancer; pharmaceutical compositions comprising Compound [I] (or a pharmaceutically acceptable salt thereof) and a taxane; kits comprising Compound [I] or a pharmaceutically acceptable salt thereof and a taxane, optionally with instructions for use; and methods of treatment comprising the simultaneous, sequential or separate administration of Compound [I] or a pharmaceutically acceptable salt thereof and a taxane to warm-blooded animal, such as man. | 01-28-2016 |